ArticleJournal of managed care & specialty pharmacy2022

Dasiglucagon demonstrates reduced costs in the treatment of severe hypoglycemia in a budget impact model.

Jordan Hinahara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.